BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7703528)

  • 1. Characterization of interleukin-4 receptors expressed on human renal cell carcinoma cells.
    Obiri NI; Puri RK
    Oncol Res; 1994; 6(9):419-27. PubMed ID: 7703528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.
    Obiri NI; Hillman GG; Haas GP; Sud S; Puri RK
    J Clin Invest; 1993 Jan; 91(1):88-93. PubMed ID: 8423237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 13 inhibits growth of human renal cell carcinoma cells independently of the p140 interleukin 4 receptor chain.
    Obiri NI; Husain SR; Debinski W; Puri RK
    Clin Cancer Res; 1996 Oct; 2(10):1743-9. PubMed ID: 9816125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suramin blocks binding of interleukin-4 to its receptors on human tumor cells and interleukin-4-induced mitogenic response.
    Leland P; Obiri N; Aggarwal BB; Puri RK
    Oncol Res; 1995; 7(5):227-35. PubMed ID: 8534928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunostaining of interleukin-4 receptor on human renal cell carcinoma.
    Varricchio F; Obiri NI; Haas GP; Puri RK
    Lymphokine Cytokine Res; 1993 Dec; 12(6):465-9. PubMed ID: 8123763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of high-affinity interleukin 4 receptors on murine sarcoma cells and receptor-mediated cytotoxicity of tumor cells to chimeric protein between interleukin 4 and Pseudomonas exotoxin.
    Puri RK; Ogata M; Leland P; Feldman GM; FitzGerald D; Pastan I
    Cancer Res; 1991 Jun; 51(11):3011-7. PubMed ID: 2032239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 4 receptor expression and growth inhibition of gastric carcinoma cells by interleukin 4.
    Morisaki T; Yuzuki DH; Lin RT; Foshag LJ; Morton DL; Hoon DS
    Cancer Res; 1992 Nov; 52(21):6059-65. PubMed ID: 1394231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of interleukin-2 and interleukin-4 receptor expression in human and ape lymphoid cell lines.
    Guizani L; Lang P; Stancou R; Bertoglio J
    Lymphokine Cytokine Res; 1993 Feb; 12(1):25-32. PubMed ID: 8457629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor upregulates interleukin-4 receptors on murine sarcoma cells.
    Puri RK; Leland P
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1424-30. PubMed ID: 8280160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine osteoblast interleukin 4 receptor expression: upregulation by 1,25 dihydroxyvitamin D3.
    Lacey DL; Erdmann JM; Tan HL; Ohara J
    J Cell Biochem; 1993 Oct; 53(2):122-34. PubMed ID: 8227185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-4-dependent up-regulation of IL-4 receptor expression in murine T and B cells.
    Renz H; Domenico J; Gelfand EW
    J Immunol; 1991 May; 146(9):3049-55. PubMed ID: 2016538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of interleukin 4 receptor expression on human lymphoid cells by cyclosporin.
    Foxwell BM; Woerly G; Ryffel B
    Eur J Immunol; 1990 May; 20(5):1185-8. PubMed ID: 2141571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain.
    Kuznetsov VA; Puri RK
    Biophys J; 1999 Jul; 77(1):154-72. PubMed ID: 10388747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells.
    Kawakami K; Leland P; Puri RK
    Cancer Res; 2000 Jun; 60(11):2981-7. PubMed ID: 10850446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of interleukin 4 receptor-associated proteins and expression of both high- and low-affinity binding on human lymphoid cells.
    Foxwell BM; Woerly G; Ryffel B
    Eur J Immunol; 1989 Sep; 19(9):1637-41. PubMed ID: 2529125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.
    Griffith TS; Fialkov JM; Scott DL; Azuhata T; Williams RD; Wall NR; Altieri DC; Sandler AD
    Cancer Res; 2002 Jun; 62(11):3093-9. PubMed ID: 12036919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4.
    Myers JN; Yasumura S; Suminami Y; Hirabayashi H; Lin Wc; Johnson JT; Lotze MT; Whiteside TL
    Clin Cancer Res; 1996 Jan; 2(1):127-35. PubMed ID: 9816099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 4 receptors on normal human B lymphocytes: characterization and regulation.
    Zuber CE; Galizzi JP; Vallé A; Harada N; Howard M; Banchereau J
    Eur J Immunol; 1990 Mar; 20(3):551-5. PubMed ID: 2318249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies block murine IL-4 receptor function.
    Beckmann MP; Schooley KA; Gallis B; Vanden Bos T; Friend D; Alpert AR; Raunio R; Prickett KS; Baker PE; Park LS
    J Immunol; 1990 Jun; 144(11):4212-7. PubMed ID: 1692858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
    Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.